Navigation Links
Monsanto Company Executives Adopt 10b5-1 Trading Plans

ST. LOUIS, Oct. 17 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) today announced that several of its executives, including: Hugh Grant, chairman, president and chief executive officer, and Robb Fraley, executive vice president and chief technology officer, have established stock trading plans in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Under these plans, the Monsanto executives have directed brokers in the sale of shares and exercise of stock options in order to diversify their personal financial portfolios. All executives have previously satisfied their Monsanto stock ownership requirements, including Mr. Grant at an amount equal to five times his annual base salary and Dr. Fraley at an amount equal to three times his annual base salary. Both Mr. Grant and Dr. Fraley hold stock in excess of their Monsanto stock ownership requirements.

Roughly 40 Monsanto executives have stock ownership requirements of varying levels. Monsanto established a stock ownership requirement in 2000 in connection with the company's initial public offering of stock. These guidelines have been amended since then, most recently in June 2006, to keep the dollar value requirements of stock ownership commensurate with base pay multiples.

In accordance with Rule 10b5-1, officers and directors of public companies may adopt plans for purchasing or selling securities in which the amount, price and date of the transactions are specified. These plans may only be entered into when the officer or director is not in possession of material, nonpublic information.

Monsanto Company is a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality. For more information on Monsanto, see:

SOURCE Monsanto Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Germantown drug company hires pharma veteran James Davidson as COO
2. Georgia stem cell company likely to stay put
3. Surgical products company wins Governors Business Plan Contest
4. Madison stem cell company gets $1M from state
5. Company still behind schedule on Milwaukee wireless project
6. Software company enters health space with RFID solutions on hold
7. Delaware company will keep NameProtect here
8. IPO-bound NimbleGen traveling in fast company
9. Wisconsin tries to woo another stem cell company
10. Company to operate in wireless Internet space
11. RedPrairie acquires Denver software company
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" or ... financial results for the quarter ended September 30, ... Canadian dollars and presented under International Financial Reporting ... ," said Andrew Rae , President ... iCo-008 are not only value enriching for this ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ - ... the request of IIROC on behalf of the Toronto ... this news release there are no corporate developments that ... price. --> --> ... --> . --> Aeterna Zentaris ...
(Date:11/24/2015)... PA (PRWEB) , ... November 24, 2015 , ... This ... entrepreneurs at competitive events in five states to develop and pitch their BIG ideas ... projects from each state are competing for votes to win the title of SAP's ...
(Date:11/24/2015)... ALBANY, New York , November 24, 2015 /PRNewswire/ ... According to a recent market research report released by ... is projected to expand at a CAGR of 17.5% ... titled "Non-invasive Prenatal Testing Market - Global Industry Analysis, ... 2022", estimates the global non-invasive prenatal testing market to ...
Breaking Biology Technology:
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
Breaking Biology News(10 mins):